BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-30 17:54 |
BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservati…
|
English | HTML • 6.0 KB | ||
| 2025-03-19 16:45 |
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BR…
|
English | HTML • 14.6 KB | ||
| 2025-03-18 16:45 |
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BR…
|
English | HTML • 14.6 KB | ||
| 2025-03-04 11:25 |
BRAIN Biotech AG: Michael Schneiders, buy
|
English | HTML • 6.0 KB | ||
| 2025-03-03 11:25 |
BRAIN Biotech AG: Michael Schneiders, buy
|
English | HTML • 6.0 KB | ||
| 2025-02-27 07:30 |
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growt…
|
English | HTML • 20.8 KB | ||
| 2025-02-27 00:00 |
Q1 statement / Q1 financial report 2024/2025
|
English | PDF • 256.3 KB | ||
| 2025-02-26 07:30 |
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growt…
|
English | HTML • 20.8 KB | ||
| 2025-02-26 00:00 |
Q1 statement / Q1 financial report 2024/2025
|
English | PDF • 256.3 KB | ||
| 2025-02-14 09:14 |
Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the P…
|
English | HTML • 15.8 KB | ||
| 2025-02-13 09:14 |
Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the P…
|
English | HTML • 15.8 KB | ||
| 2025-02-10 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.10.2023 bis zum 30.09.2024
|
German | ZIP • 553.7 KB | ||
| 2025-02-10 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.10.2023 bis zum 30.09.2024
|
German | ZIP • 1.3 MB | ||
| 2025-02-05 15:04 |
BRAIN Biotech AG: Bekanntmachung der Einberufung zur Hauptversammlung am 18.03.…
|
German | HTML • 108.4 KB | ||
| 2025-01-17 11:26 |
BRAIN Biotech AG: Adriaan Moelker, buy
|
English | HTML • 8.5 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
